Eye Care
FDA Officials OK Dextenza for Post-Ophthalmic Surgery Pain Management
FDA Officials OK Dextenza for Post-Ophthalmic Surgery Pain Management
Safety data came from both phase 3 studies as well as a phase 2 study of Dextenza, which together totaled 351 patients.
Read More >>
This Halloween, Discuss Potential Dangers of Costume Contacts
FDA Approves First Drug for Neurotrophic Keratitis
CDC: Poor Contact Lens Hygiene Increases Risk of Infection
Solution for Treating Dry Eye Disease Approved by FDA
CDC Addresses Need for Eye Care with New Surveillance System
Eye Catching Study: The Truth About Benzalkonium Chloride
Herpes Zoster Ophthalmicus Increasing
View more articles >>
Clinical Trials
Comparison of Efficacy and Safety of Mitomycin and Aflibercept Used to Support Primary Trabeculectomy.
Diagnostic Efficacy of CNN in Differentiation of Visual Field
Performance and Safety of the ARGOS-SC01 Suprachoroidal Pressure Sensor in Patients With Glaucoma Undergoing Non-penetrating Glaucoma Surgery
Measurement of the Effect of Gingko Biloba Extract on Ocular and Nailfold Blood-flow in NTG
A Clinical Study to Evaluate the Efficacy and Safety of CKD-351
Multimedia: Videos
Research to Cure Vision and Brain Disorders
Research to Cure Vision and Brain Disorders
Glaucoma Treatments
Glaucoma Treatments
Glaucoma Overview
Glaucoma Overview